野田 航介 業績集

英文業績(1998年から現在まで)

IF (impact factor): 2021年ISI Journal Citation Reportsより

 

本数

IF合計

一編あたり

First author

10

50.686

5.069

Corresponding author

38

124.540

3.277

Second author

23

110.925

4.823

その他

108

490.079

4.538

英文全業績

179

776.230

4.336

   以下、Corresponding authorの論文の番号に印を付します

 

  1. Ando R, Hirooka K, Saito M, Kase S, Noda K, Ishida S. Two-year clinical outcomes of triple therapy with photodynamic therapy, anti-vascular endothelial growth factor agent, and triamcinolone acetonide for neovascular age-related macular degeneration. Jpn J Ophthalmol. Epub ahead of print
  2. Mitamura M, Noda K, Kase S, Hirooka K, Ishida S. Retinal hypoperfusion detected by wide-field optical coherence tomographic angiography in a case of retinal racemose hemangioma. Retin Cases Brief Rep. Epub ahead of print
  3. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isobai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. Relationship between Brachial-Ankle Pulse Wave Velocity and Fundus Arteriolar Area Calculated Using a Deep-Learning Algorithm. Curr Eye Res. 2022; 47: 1534-1537
  4. Hase K, Namba K, Wada H, Tsuji H, Maeda A, Murata T, Otsuka R, Iwata D, Kanda A, Noda K, Kitaichi N, Seino K, Ishida S. Macrophage-like iPS-derived suppressor cells reduce Th1-mediated immune response to a retinal antigen. Curr Eye Res. 2022; 46: 1908-1916
  5. Hasegawa A, Noda K, Fujiya A, Hirooka K, Anzai T, Ishida S. Outer Retinal Abnormalities in a Patient with Danon Disease. Retin Cases Brief Rep. 2022; 16: 619-621
  6. Hirooka K, Saito M, Yamashita Y, Hashimoto Y, Terao N, Koizumi H, Noda K, Ishida S. Imbalanced Choroidal Circulation in Eyes with Asymmetric Dilated Vortex Vein. Jpn J Ophthalmol. 2022; 66: 14-18
  7. Kase S, Hasegawa A, Hirooka K, Endo H, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with radiation retinopathy. Int J Ophthalmol. 2022; 15: 172-174
  8. Komori R, Takamura Y, Yamada Y, Morioka M, Matsubara H, Hirano T, Mitamura Y, Shimizu M, Kusuhara S, Murakami T, Nihei R, Ueda T, Kunikata H, Jujo T, Terasaki H, Nagasato D, Noda K, Osaka R, Nagai K, Yoshida S, Nozaki M, Noma H, Ishigooka G, Takahashi A, Sawada O Kimura K, Inatani M. Impact of the COVID-19 Pandemic on Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Japan. J Clin Med. 2022; 11: 6794
  9. Murata M, Noda K, Kase S, Hase K, Wu D, Ando R, Ishida S. Placental growth factor stabilizes VEGF receptor-2 protein in retinal pigment epithelial cells by downregulating glycogen synthase kinase 3 activity. J Biol Chem. 2022; 298: 102378
  10. Noda T, Noda K, Hirooka K, Kase S, Ishida S. Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment. Am J Ophthalmol Case Rep. 2022; 27: 101568
  11. Shimizu H, Shimizu M, Nakano T, Noda K, Tanito M. Multimodal Imaging Findings in Retinopathy Associated with Facioscapulohumeral Muscular Dystrophy before and after Treatment with Intravitreal Aflibercept and Laser Photocoagulation. Case Rep Ophthalmol. 2022;13:556–561
  12. Sone R, Noda K, Hirooka K, Saito M, Ishida S. Insidious progression of atrophic lesions in a case of posterior polar annular choroidal dystrophy. Am J Ophthalmol Case Rep. 2022; 28: 101708
  13. Tanimukai T, Noda K, Hirooka K, Kase S, Ishida S. Non-invasive imaging of a vasoproliferative retinal tumor treated with cryopexy. Case Rep Ophthalmol. 2022; 13: 611-616
  14. Fukutsu K, Murata M, Kikuchi K, Yoshida S, Noda K, Ishida S. ROCK1 mediates retinal glial cell migration promoted by acrolein. Front Med. 2021; 8: 717602
  15. Fukutsu K, Saito M, Noda K, Murata M, Kase S, Shiba R, Isogai N, Asano Y, Hanawa N, Dohke M, Kase M, Ishida S. A deep learning architecture for vascular area measurement in fundus images. Ophthalmology Science. 2021; 1: 100004
  16. Hase K, Kase S, Kanda A, Shinmei Y, Noda K, Ishida S. Expression of vascular endothelial growth factor-C in the trabecular meshwork of patients with neovascular glaucoma and primary open-angle glaucoma. J Clin Med. 2021; 10: 2977
  17. Hashimoto Y, Saito W, Kanaizumi S, Saito M, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with acute zonal occult outer retinopathy according to anti-retinal antibody status. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 2967-2976
  18. Hirano T, Toriyama Y, Takamura Y, Sugimoto M, Nagaoka T, Sugiura Y, Okamoto F, Saito M, Noda K, Yoshida S, Ishibazawa A, Sawada O, Murata T. Outcomes of a 2-year treat-and-extend regimen with aflibercept for diabetic macular edema. Sci Rep. 2021; 11: 4488
  19. Hirano T, Toriyama Y, Takamura Y, Sugimoto M, Nagaoka T, Sugiura Y, Okamoto F, Saito M, Noda K, Yoshida S, Ishibazawa A, Sawada O, Murata T. Treat-and-extend therapy with aflibercept for diabetic macular edema: a prospective clinical trial. Jpn J Ophthalmol. 2021; 65: 354-362
  20. Kase S, Noda K, Ishida S. Histological observation in pachyvessels in a patient with choroidal melanoma. Int J Ophthalmol. 2021; 14: 777-779
  21. Shinkai A, Saito W, Hashimoto Y, Saito M, Kase S, Noda K, Ishida S. Morphological features of macular telangiectasia type 2 in Japanese patients. Graefes Arch Clin Exp Ophthalmol. 2021; 259: 1179-1189
  22. Takamura Y, Kida T, Noma H, Inoue M, Yoshida S, Nagaoka T, Noda K, Yomada Y, Morioka M, Gozawa M, Matsumura T, Inatomi M. The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen. J Clin Med. 2021; 10: 5738
  23. Ishizuka ET, Kanda A, Shinmei Y, Ohguchi T, Tagawa Y, Hase K, Yamamoto T, Noda K, Chin S, Ishida S. Receptor-Associated Prorenin System in the Trabecular Meshwork of Patients with Primary Open-Angle Glaucoma and Neovascular Glaucoma. J Clin Med. 2020; 9: E2336
  24. Kanda A, Hirose I, Noda K, Murata M, Ishida S. Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization. J Cell Mol Med. 2020; 24: 4589-4599
  25. Kataoka K, Kase S, Noda K, Ishida S. Laser speckle flowgraphy findings in a patient with choroidal macrovessel. Ophthalmol Retina. 2020; 4: 1123-1124
  26. Kikuchi K, Dong Z, Shinmei Y, Murata M, Kanda A, Noda K, Harada T, Ishida S. Cytoprotective effect of astaxanthin in a model of normal intraocular pressure glaucoma. J Ophthalmol. 2020; 2020: 9539681
  27. Kikuchi K, Murata M, Noda K, Kase S, Tagawa Y, Kageyama Y, Shinohara M, Sasase T, Ishida S. Diabetic Cataract in Spontaneously Diabetic Torii Fatty Rats. J Diabetes Res. 2020; 2020: 3058547
  28. Liu Y, Kitaichi N, Wu D, Hase K, Satoh M, Iwata D, Namba K, Kanda A, Noda K, Itai A, Iwabuchi K, Ishida S. Attenuation of experimental autoimmune uveoretinitis in mice by IKKβ inhibitor IMD-0354. Biochem Biophys Res Commun. 2020; 525: 589-594
  29. Liu Y, Noda K, Murata M, Wu D, Kanda A, Ishida S. Blockade of Platelet-Derived Growth Factor Signaling Inhibits Choroidal Neovascularization and Subretinal Fibrosis in Mice. J Clin Med. 2020; 9: E2242
  30. Murata M, Noda K, Ishida S. Pathological role of unsaturated aldehyde acrolein in diabetic retinopathy. Front Immunol. 2020; 11: 589531
  31. Saito M, Noda K, Saito W, Hirooka K, Hashimoto Y, Ishida S. Increased choroidal blood flow and choroidal thickness in patients with hypertensive chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 233-240
  32. Takamura Y, Yamada Y, Noda K, Morioka M, Hashimoto Y, Gozawa M, Matsumura T, Inatani M. Characteristic distribution of microaneurysms and capillary dropouts in diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2020; 258: 1625-1630
  33. Wu D, Kanda A, Liu Y, Noda K, Murata M, Ishida S. Involvement of Müller glial autoinduction of transforming growth factor-β in diabetic fibrovascular proliferation via glial-mesenchymal transition. Invest Ophthalmol Vis Sci. 2020; 61: 29
  34. Wu D, Noda K, Murata M, Liu Y, Kanda A, Ishida S. Regulation of Spermine Oxidase through Hypoxia-inducible Factor-1α Signaling in Retinal Glial Cells under Hypoxic Conditions. Invest Ophthalmol Vis Sci. 2020; 61: 52
  35. Hase K, Kanda A, Noda K, Ishida S. Increased plasma galectin-1 correlates with advanced glycation end products and interleukin-1β in patients with proliferative diabetic retinopathy. Int J Ophthalmol. 2019; 12: 692-694
  36. Hashimoto Y, Saito W, Hasegawa Y, Noda K, Ishida S. Involvement of inner choroidal layer in choroidal thinning during regression of multiple evanescent white dot syndrome. J Ophthalmol. 2019; 2019: 6816925
  37. Hashimoto Y, Saito W, Namba K, Mizuuchi K, Iwata D, Noda K, Kanda A, Ishida S. Comparison of clinical characteristics in patients with Vogt-Koyanagi-Harada disease with and without anti-retinal antibodies. Graefes Arch Clin Exp Ophthalmol. 2019; 257: 1751-1758
  38. Hirose I, Kanda A, Noda K, Ishida S. Glucocorticoid receptor inhibits Müller glial galectin-1 expression via DUSP1-dependent and -independent deactivation of AP-1 signalling. J Cell Mol Med. 2019; 23: 6785-6796
  39. Kanda A, Noda K, Hirose I, Ishida S. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal Sci Rep. 2019; 9: 673
  40. Liu Y, Kanda A, Wu D, Ishizuka ET, Kase S, Noda K, Ichihara A, Ishida S. Suppression of choroidal neovascularization and fibrosis by a novel RNAi therapeutic agent against (pro)renin receptor. Mol Ther Nucleic Acids. 2019; 17: 113-125
  41. Murata M, Noda K, Yoshida S, Saito M, Fujiya A, Kanda A, Ishida S. Unsaturated Aldehyde Acrolein Promotes Retinal Glial Cell Migration. Invest Ophthalmol Vis Sci. 2019; 60: 4425-4435
  42. Tagawa Y, Noda K, Ohguchi T, Tagawa Y, Ishida S, Kitaichi N. Corneal hyperalgesia in patients with short tear film break-up time dry eye. Ocul Surf. 2019; 17: 55-59
  43. Wu D, Kanda A, Liu Y, Kase S, Noda K,  Ishida S. Galectin-1 promotes choroidal neovascularization and subretinal fibrosis mediated via epithelial-mesenchymal transition. FASEB J. 2019; 33: 2498-2513
  44. Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi S, Mori S, Noda K, Shinoda K, Ishida S. Clinical features of Japanese patients with anti-α-enolase antibody-positive autoimmune retinopathy: Novel subtype of multiple drusen. Am J Ophthalmol2018; 196: 181-196
  45. Kase S, Mori S, Noda K, Ishida S. Anterior proliferative vitreoretinopathy in a patient with Coats disease. Int J Ophthalmol. 2018; 11: 343-345
  46. Tanaka A, Saito W, Kase S, Ishijima K, Noda K, Ishida S. Role of the epipapillary membrane in maculopathy associated with cavitary optic disc anomalies: morphology, surgical outcomes, and histopathology. J Ophthalmol. 2018; 5680503
  47. Saito M, Noda K, Saito W, Ishida S. Relationship between choroidal blood flow velocity and choroidal thickness in patients with regression of acute central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol. 2017; 7: 44266
  48. Yoshida S, Murata M, Noda K, Matsuda T, Saito M, Saito W, Kanda A, Ishida S. Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells. Jpn J Ophthalmol. 2018; 62: 256-264
  49. Dong Y, Kanda A, Noda K, Saito W, Ishida S. Pathologic roles of receptor-associated prorenin system in idiopathic epiretinal membrane. Sci Rep. 2017; 7: 44266
  50. Dong Y, Noda K, Murata M, Yoshida S, Saito W, Kanda A, Ishida S. Localization of Acrolein-lysine adduct in fibrovascular tissues of proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 111-117
  51. Hase K, Kanda A, Hirose I, Noda K, Ishida S. Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy. PLoS ONE.2017; 12: e0189696
  52. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Takita A, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual field impairment in acute zonal occult outer retinopathy. J Ophthalmol. 2017; 2017:2371032
  53. Kanda A, Dong Y, Noda K, Saito W, Ishida S. Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy. Sci Rep. 2017; 7: 16168
  54. Kanda A, Ishizuka ET, Shibata A, Matsumoto T, Toyofuku H, Noda K, Namba K, Ishida S. A novel single-strand RNAi therapeutic agent targeting (pro)renin receptor suppresses ocular inflammation. Mol Ther Nucleic Acids. 2017; 7: 116-126
  55. Kinoshita S, Ohguchi T, Noda K, Murata M, Yasueda S, Obata H, Matsunaga T, Fukushima T, Kanda A, Ishida S. Evaluation of the safety and tolerability of conjunctival ring for posterior segment of the eye. Curr Eye Res. 2017; 30: 1-6
  56. Matsuda T, Noda K, Murata M, Kawasaki A, Kanda A, Mashima Y, Ishida S.Vascular Adhesion Protein-1 Blockade Suppresses Ocular Inflammation after Retinal Laser Photocoagulation in Mice. Invest Ophthalmol Vis Sci. 2017; 58: 3254-3261
  57. Murata M, Noda K, Kawasaki A, Yoshida S, Dong Y, Saito M, Dong Z, Ando R, Mori S, Saito W, Kanda A, Ishida S. Soluble vascular adhesion protein-1 mediates spermine oxidation as semicarbazide-sensitive amine oxidase: possible role in proliferative diabetic retinopathy. Curr Eye Res. 2017; 42: 1674-1683
  58. Dong Y, Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Inafuku S, Tagawa Y, Ishizuka ET, Saito W, Murata M, Kanda A, Noda K, Ishida S. Phosphorylation of alphaB-crystallin in epiretinal membrane of human proliferative diabetic retinopathy. Int J Ophthalmol.  2016; 9: 1100-1105
  59. Dong Y, Kase S, Dong Z, Fukuhara J, Tagawa Y, Ishizuka ET, Murata M, Shinmei Y, Ohguchi T, Kanda A, Noda K, Ishida S. Regulation of vascular endothelial growth factor-C by tumor necrosis factor-α in the conjunctiva and pterygium. Int J Mol Med. 2016; 38: 545-550
  60. Dong Z, Shinmei Y, Dong Y, Inafuku S, Fukuhara J, Ando R, Kitaichi N, Kanda A, Tanaka K, Noda K, Harada T, Chin S, Ishida S. Effect of geranylgeranylacetone on the protection of retinal ganglion cells in a mouse model of normal tension glaucoma. Heliyon. 2016; 2: e00191
  61. Hashimoto Y, Saito W, Saito M, Hasegawa Y, Mori S, Noda K, Ishida S. Relationship between choroidal thickness and visual impairment in multiple evanescent white dot syndrome. Acta Ophthalmol. 2016; 94: e804-e806
  62. Hirooka K, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of acute posterior multifocal placoid pigment epitheliopathy. Jpn J Ophthalmol. 2016; 60: 172-178
  63. Kase S, Saito W, Mori S, Saito M, Ando R, Dong Z, Suzuki T, Noda K, Ishida S. Clinical and histological evaluation of large macular holes surgery using the inverted internal limiting membrane flap technique. Clin Ophthalmol. 2016; 11: 9–14
  64. Kinoshita S, Noda K, Saito W, Kanda A, Ishida S. Vitreous levels of vascular endothelial growth factor-B in proliferative diabetic retinopathy. Acta Ophthalmol. 2016; 94: e521-523
  65. Fujiya A, Noda K, Yoshida S, Saito W, Ishida S. Increased Vascular Endothelial Growth Factor Level in the Subretinal Fluid of Eye with Vasoproliferative Retinal Tumors. Retin Cases Brief Rep. 2015; 9: 154-156
  66. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Decreased choroidal blood flow velocity in the pathogenesis of multiple evanescent white dot syndrome. Graefes Arch Clin Exp Ophthalmol. 2015; 253: 1457-64
  67. Hashimoto Y, Saito W, Fujiya A, Yoshizawa C, Hirooka K, Mori S, Noda K, Ishida S. Changes in inner and outer retinal layer thicknesses after vitrectomy for idiopathic macular hole: Implications for visual prognosis. PLoS One. 2015; 10: e0135925
  68. Hashimoto Y, Saito W, Saito M, Hirooka K, Mori S, Noda K, Ishida S. Increased choroidal blood flow velocity with regression of unilateral acute idiopathic maculopathy. Jpn J Ophthalmol. 2015; 59: 252-260
  69. Inafuku S, Noda K, Amano M, Nishimura S, Ishida S. Increase of sialylated N-glycans in eyes with neovascular glaucoma secondary to proliferative diabetic retinopathy. Curr Eye Res. 2015 Jul 15:1-4
  70. Inafuku S, Noda K, Amano M, Ohashi T, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. Alteration of N-glycan profiles in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2015; 56: 5316-5322
  71. Kanda A, Noda K, Ishida S. ATP6AP2/(pro)renin receptor contributes to glucose metabolism via stabilizing the pyruvate dehydrogenase E1 ß subunit. J Biol Chem. 290:9690-9700, 2015
  72. Kanda A, Noda K, Saito W, Ishida S. Aflibercept traps galectin-1, an angiogenic factor associated with diabetic retinopathy. Sci Rep. 5: 17946, 2015
  73. Morooka S, Hoshina M, Kii I, Okabe T, Kojima H, Inoue N, Okuno Y, Denawa M, Yoshida S, Fukuhara J, Ninomiya K, Ikura T, Furuya T, Nagano T, Noda K, Ishida S, Hosoya T, Ito N, Yoshimura N, Hagiwara M. Identification of a dual Inhibitor of SRPK1 and CK2 that attenuates pathological angiogenesis of macular degeneration in mice. Mol Pharmacol. 2015; 88: 316-325
  74. Saito M, Saito W, Hirooka K, Hashimoto Y, Mori S, Noda K, Ishida S. Pulse waveform changes in macular choroidal hemodynamics with regression of acute central serous chorioretinopathy. Invest Ophthalmol Vis Sci.  2015; 56: 6515-6522
  75. Saito S, Saito W, Saito M, Hashimoto Y, Mori S, Noda K, Namba K, Ishida S. Acute zonal occult outer retinopathy in Japanese patients: Clinical features, visual function, and factors affecting visual function. PLoS One. 2015;10:e0125133
  76. Ando R, Noda K, Tomaru U, Kamoshita M, Ozawa Y, Notomi S, Hisatomi T, Noda M, Kanda A, Ishibashi T, Kasahara M, Ishida S. Decreased Proteasomal Activity Causes Photoreceptor Degeneration in Mice. Invest Ophthalmol Vis Sci. 2014; 55: 4682-4690
  77. Ando R, Noda K, Namba S, Saito W, Kanda A, Ishida S. Aqueous humor levels of placental growth factor in diabetic retinopathy. Acta Ophthalmol. 2014; 92: 245-6
  78. Dong Z, Iwata D, Kitaichi N, Takeuchi M, Sato M, Endo N, Iwabuchi K, Ando R, Fukuhara J, Kinoshita S, Lennikov A, Kitamura M, Mizuuchi K, Kanda A, Noda K, Namba K, Yamagishi S, Ohno S, Ishida S. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde derived-advanced glycation end product formation. J Leukoc Biol. 2014; 96: 1077-1085
  79. Hashimoto Y, Saito W, Noda K, Ishida S. Acquired focal choroidal excavation associated with multiple evanescent white dot syndrome: observations at onset and a pathogenic hypothesis. BMC Ophthalmol. 2014, 14:135
  80. Hashimoto Y, Saito W, Saito M, Hirooka K, Fujiya A, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases after vitrectomy for epiretinal membrane and visual improvement positively correlates with photoreceptor outer segment length. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 219-226
  81. Hashimoto Y, Saito W, Saito M, Hirooka K, Yoshizawa C, Noda K, Ishida S. Retinal outer layer thickness increases with regression of multiple evanescent white dot syndrome and visual improvement positively correlates with photoreceptor outer segment length. Acta Ophthalmol. 2014; 92: 591-592
  82. Hirooka K, Saito W, Noda K, Ishida S. Enhanced-depth imaging optical coherence tomography and laser speckle flowgraphy in a patient with acute macular neuroretinopathy. Ocul Immunol Inflamm. 2014; 22: 485-489
  83. Inafuku S, Noda K, Amano M, Ohashi, Yoshizawa C, Saito W, Kanda A, Nishimura S, Ishida S. A comparison of N-glycan profiles in human plasma and vitreous fluid. Graefes Arch Clin Exp Ophthalmol. 2014; 252: 1235-1243
  84. Ishizuka ET, Kanda A, Kase S, Noda K, Ishida S. Involvement of the Receptor-Associated Prorenin System in the Pathogenesis of Human Conjunctival Lymphoma. Invest Ophthalmol Vis Sci. 2014; 56: 74-80
  85. Kinoshita S, Noda K, Tagawa Y, Inafuku S, Dong Y, Fukuhara J, Dong Z, Ando R, Kanda A, Ishida S. Genistein Attenuates Choroidal Neovascularization. J Nutr Biochem. 2014; 25: 1177-1182
  86. Kinoshita S, Kase S, Ando R, Dong Z, Fukuhara J, Dong Y, Takashina S, Noda K, Noda M, Kanda A, Ishida S. Expression of vascular endothelial growth factor in human ocular adnexal lymphoma. Invest Ophthalmol Vis Sci. 2014; 55: 3461-7
  87. Lennikov A, Kitaichi N, Noda K, Mizuuchi K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with the sea urchin pigment echinochrome in rats. Mol Vis.  2014; 20: 171-177
  88. Noda K, Nakao S, Zandi S, Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes:  New insight on the inflammatory paradigm. FASEB J. 2014; 28: 2038-46
  89. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Shinmei Y, Noda K, Ishida S. Correlation between decreased choroidal blood velocity and the pathogenesis of acute zonal occult outer retinopathy. Clin Experiment Ophthalmol.2014; 42: 139-50
  90. Yoshizawa C, Saito W, Noda K, Ishida S. Pars plana vitrectomy for a patient with macular schisis associated with peripapillary intrachoroidal cavitation. Ophthalmic Surg Lasers Imaging Retina. 2014; 45: 350-353
  91. Dong Z, Noda K, Kanda A, Fukuhara J, Ando R, Murata M, Saito W, Hagiwara M, Ishida S. Specific inhibition of serine/arginine-rich protein kinase attenuates choroidal neovascularization. Mol Vis. 2013; 19:536-543
  92. Dong Z, Kase S, Ando R, Fukuhara J, Kinoshita S, Dong Y, Takashina S, Kanda A, Noda M, Noda K, Ishida S. Expression of alphaB-crystallin and vascular endothelial growth factor in conjunctival squamous cell carcinoma. Anticancer Res. 2013; 33: 3745-3751
  93. Fukuhara J, Kase S, Ohashi T, Ando R, Dong Z, Noda K, Ohguchi T, Kanda A, Ishida S. Expression of vascular endothelial growth factor C in human pterygium. Histochem Cell Biol. 2013; 139: 381-389
  94. Fukuhara J, Noda K, Murata M, Namba S, Kinoshita S, Dong Z, Ando R, Lennikov A, Kanda A, Ishida S. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor. Invest Ophthalmol Vis Sci. 2013; 54: 274-279
  95. Hirooka K, Saito W, Noda K, Ishida S. A patient with acute macular neuroretinopathy and central retinal vein occlusion. Clin Ophthalmol. 2013; 7: 1447-1450
  96. Kanda A, Noda K, Saito W, Ishida S. Vitreous renin activity correlates with vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol. 2013; 97: 666-668
  97. Kanda A, Noda K, Yuki K, Ozawa Y, Furukawa T, Ichihara A, Ishida S. Atp6ap2/(pro)renin receptor interacts with Par3 as a cell polarity determinant required for laminar formation during retinal development in mice. J Neurosci. 2013; 33: 19341-19351
  98. Kase S, Rao NA, Yoshikawa H, Fukuhara J, Noda K, Kanda A, Ishida S. Expression of vascular endothelial growth factor in eyes with Coats disease. Invest Ophthalmol Vis Sci. 2013; 54: 57-62
  99. Lennikov A, Kitaichi N, Kase S, Noda K, Horie Y, Nakai A, Ohno S, Ishida S. Induction of heat shock protein 70 ameliorates ultraviolet-induced photokeratitis in mice. Int J Mol Sci. 2013; 14: 2175-2189
  100. Noda K, Ishida S. Role of chronic inflammation in diabetic retinopathy. Inflamm Regen. 2013; 33: 230-237
  101. Saito W, Kase S, Fujiya A, Dong Z, Noda K, Ishida S. Expression of vascular endothelial growth factor (VEGF) and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors. 2013; 33: 1959-1967
  102. Saito M, Saito W, Hashimoto Y, Yoshizawa C, Fujiya A, Noda K, Ishida S. Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy. Br J Ophthalmol. 2013; 251: 1447-1449
  103. Takashina S, Saito W, Noda K, Katai M, Ishida S. Membrane tissue on the optic disc may cause macular schisis associated with a glaucomatous optic disc without optic disc pits. Clin Ophthalmol. 2013; 7: 883-887
  104. Yoshikawa N, Noda K, Ozawa Y, Mashima Y, Ishida S. Blockade for vascular adhesion protein-1 suppresses pathological neovascularization in oxygen-induced retinopathy. Acta Ophthalmol. 2013; 91: e409-e410 
  105. Yoshikawa N, Noda K, Shinoda H, Uchida A, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes. J Diabetes Complications. 2013; 27: 162-166
  106. Yoshizawa C, Saito W, Hirose S, Kitamei H, Noda K, Ishida S. Photodynamic therapy combined with intravitreal bevacizumab and sub-tenon triamcinolone acetonide injections for age-related macular degeneration. Jpn J Ophthalmol. 2013; 57: 68-73
  107. Dong Z, Kase S, Ando R, Fukuhara J, Saito W, Kanda A, Murata M, Noda K, Ishida S. AlphaB-crystallin expression in epiretinal membrane of human proliferative diabetic retinopathy. Retina. 2012; 32: 1190-1196
  108. Fukuhara J, Kase S, Noda K, Kanda A, Murata M, Noda M, Ando R, Dong Z, Ishida S. Immunolocalization of vascular adhesion protein-1 in human conjunctival tumors. Ophthalmic Res. 2012; 48: 33-37
  109. Hisatomi T, Nakao S, Murakami Y, Noda K, Nakazawa T, Notomi S, Connolly E, She H, Almulki L, Ito Y, Vavvas DG, Ishibashi T, Miller JW. The regulatory roles of apoptosis-inducing factor in the formation and regression processes of ocular neovascularization. Am J Pathol. 2012; 181: 53-61
  110. Horie Y, Meguro A, Kitaichi N, Lee E B, Kanda A, Noda K, Song Y W, Park K S, Namba K, Ota M, Inoko H, Mizuki N, Ishida S, Ohno S. Replication of a microsatellite genome-wide association study of Behcet disease in a Korean population. Rheumatology. 2012; 51: 983-986
  111. Kanda A, Noda K, Saito W, Ishida S. (Pro)renin receptor is associated with angiogenic activity in proliferative diabetic retinopathy. Diabetologia. 2012; 55: 3104-3113
  112. Kanda A, Noda K, Oike Y, Ishida S. Angiopoietin-like protein 2 mediates endotoxin-induced acute inflammation in the eye. Lab Invest. 2012; 92: 1553-1563
  113. Lennikov A, Kitaichi N, Fukase R, Murata M, Noda K, Ando R, Ohguchi T, Kawakita T, Ohno S, Ishida S. Amelioration of ultraviolet-induced photokeratitis in mice treated with astaxanthin eye drops. Mol Vis. 2012; 18: 455-464
  114. Lennikov A, Kitaichi N, Noda K, Ando R, Dong Z, Fukuhara J, Kinoshita S, Namba K, Mizutani M, Fujikawa T, Itai A, Ohno S, Ishida S. Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats. Mol Vis. 2012; 18: 2586-2597
  115. Murata M, Noda K, Fukuhara J, Kanda A, Kase S, Saito W, Ozawa Y, Mochizuki S, Kimura S, Mashima Y, Okada Y, Ishida S. Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2012; 53: 4055-62
  116. Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012; 2012: 279037
  117. Sasaki M, Yuki K, Kurihara T, Miyake S, Noda K, Kobayashi S, Ishida S, Tsubota K, Ozawa Y. Biological role of lutein in the light-induced retinal degeneration. J Nutr Biochem. 2012; 23: 423-429
  118. Yoshikawa N, Noda K, Ozawa Y, Tsubota K, Mashima Y, Ishida S. Blockade of vascular adhesion protein-1 attenuates choroidal neovascularization. Mol Vis. 2012; 18: 593-600
  119. Ando R, Kase S, Ohashi T, Dong Z, Fukuhara J, Kanda A, Murata M, Noda K, Kitaichi N, Ishida S. Tissue factor expression in human pterygium. Mol Vis. 2011; 17:63-69
  120. Hashimoto A, Hashimoto S, Ando R, Noda K, Ogawa E, Kotani H, Hirose M, Menju T, Morishige M, Manabe T, Toda Y, Ishida S, Sabe H. GEP100-Arf6-AMAP1-Cortactin pathway frequently used in cancer invasion is activated by VEGFR2 to promote angiogenesis. PLoS ONE. 2011; 6: 1-11
  121. Hirasawa M, Noda K, Noda S, Suzuki M, Ozawa Y, Shinoda K, Inoue M, Ogawa Y, Tsubota K, Ishida S. Transcriptional factors associated with epithelial-mesenchymal transition in choroidal neovascularization. Mol Vis. 2011; 17: 1222-1230
  122. Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, Tsubota K. Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci. 2011; 52: 9142-9148
  123. Kubota M, Shimmura S, Kubota S, Miyashita H, Kato N, Noda K, Ozawa Y, Usui T, Ishida S, Umezawa K, Kurihara T, Tsubota K. Hydrogen and N-acetyl-L-cysteine rescue oxidative stress-induced angiogenesis in a mouse corneal alkali-burn model. Invest Ophthalmol Vis Sc 2011; 52: 427-33
  124. Nakao S, Noda K, Zandi S, Sun D, Taher M, Schering A, Xie F, Mashima Y, Hafezi-Moghadam A. VAP-1-mediated M2 macrophage infiltration underlies IL-1β- but not VEGF-A-induced lymph- and angiogenesis. Am J Pathol. 2011;178:1913-1921
  125. Noda M, Noda K, Ideta S, Nakamura Y, Ishida S, Inoue M, Tsubota K. Repair of blowout orbital floor fracture by periosteal suturing. Clin Exp Ophthalmol. 2011; 39: 364-369
  126. Suzuki M, Ozawa Y, Kubota S, Hirasawa M, Miyake S, Noda K, Tsubota K, Kadonosono K, Ishida S. Neuroprotective response after photodynamic therapy: Role of vascular endothelial growth factor. J Neuroinflamm. 2011; 8: 176
  127. Yuki K, Ozawa Y, Yoshida T, Kurihara T, Hirasawa M, Ozeki N, Shiba D, Noda K, Ishida S, Tsubota K. Retinal ganglion cell loss in superoxide dismutase 1-deficiency. Invest Ophthalmol Vis Sci. 2011; 52: 4143-4150
  128. Almulki L, Noda K, Nakao S, Hisatomi T, Thomas KL, Hafezi-Moghadam A.Localization of vascular adhesion protein-1 (VAP-1) in the human eye. Exp EyeRes. 2010; 90: 26-32
  129. Kubota S, Kurihara T, Ebinuma M, Kubota M, Yuki K, Sasaki M, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Resveratrol prevents light-induced retinal degeneration via suppressing activator protein-1 activation. Am J Pathol.  2010; 177: 1725-31
  130. Kurihara T, Kubota Y, Ozawa Y, Takubo K, Noda K, Simon MC, Johnson RS, Suematsu M, Tsubota K, Ishida S, Goda N, Suda T, Okano H. Von Hippel-Lindau protein regulates transition from fetal to adult circulatory system in retina. Development. 2010; 137: 1563-71
  131. Nakao S, Maruyama S, Souska Z, Mark M, Mahdi T, Noda K, Nusayr E, Doetschman T, Hafezi-Moghadam A. Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J. 2010; 24: 504-13
  132. Noda K, Melhorn M, Zandi S, Frimmel S, Tayyari F, Nakao S, Hisatomi T, Almulki L, Pronczuk A, Hayes KC, Hafezi-Moghadam A. An animal model of spontaneous metabolic syndrome: Nile grass rat. FASEB J. 2010; 24: 2443-53
  133. Sasaki M, OzawaY, Kurihara T, Kubota S, Yuki K, Noda K, Kobayashi S, Ishida S, Tsubota K. Neurodegenerative influence of oxidative stressin the retina of diabetic mice. Diabetologia. 2010; 53: 971-9
  134. Suzuki M, Noda K, Kubota S, Hirasawa M, Ozawa Y, Tsubota K, Mizuki N, Ishida S. Eicosapentaenoic acid suppresses ocular inflammation in endotoxin-induced uveitis. Mol Vis. 2010; 16: 1382–88
  135. Tomita Y, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Secondary macular hole formation with presumed evulsion of foveal hard exudates in a patient with diabetic retinopathy. Jpn J Ophthalmol. 2010; 54: 366-8
  136. Kurihara T, Omoto M, Noda K, Ebinuma M, Kubota S, Koizumi H, Yoshida S, Ozawa Y, Shimmura S, Ishida S, Tsubota K. Retinal phototoxicity in a novel murine model of intraocular lens implantation. Mol Vis. 2009; 15: 2751-61
  137. Almulki L, Noda K, Amini R, Schering A, Garland RC, Nakao S, Nakazawa T, Hisatomi T, Thomas KL, Masli S, Hafezi-Moghadam A. Surprising up-regulation of P-selectin glycoprotein ligand-1 (PSGL-1) in endotoxin-induced uveitis. FASEB J. 2009; 23: 929-39
  138. Castillo N, Zandi S, Nakao S, Ito Y, Noda K, She H, Ahmed M, Frimmel S,Ablonczy S, Hafezi-Moghadam A. Atrial Natriuretic Peptide Reduces Vascular Leakage and Choroidal Neovascularization. Am J Pathol. 2009; 175: 2343-50
  139. Hirasawa M, Noda K, Shinoda H, Ozawa Y, Tsubota K, Ishida S. Secondary macular hole associated with central retinal vein occlusion treated with corticosteroid injection. Jpn J Ophthalmol. 2009; 53: 279-81
  140. Kubota S, Kurihara T, Mochimaru H, Satofuka S, Noda K, Ozawa Y, Oike Y, Ishida S, Tsubota K. Resveratrol prevents ocular inflammation in endotoxin-induced uveitis via inhibiting oxidative damage and nuclear factor-{kappa}B activation. Invest Ophthalmol Vis Sci. 2009; 50: 3512-3519
  141. Kurihara T, Suzuki K, Noda K, Kawamura R, Nagai N, Shinoda H, Shinoda K, Tsubota K, Ishida S, Inoue M. New retractor capable of aspirating fluids during scleral buckling surgery. Retina. 2009; 29: 1542-4
  142. Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, Koto T, Kurihara T, Noda K, Ozawa Y, Ishimoto T, Kawakami Y, Tanihara H, Saya H, Ishida S, Tsubota K. Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci. 2009; 50: 4410-4415
  143. Noda K, Nakao S, Zandi S, Engelstädter V, Mashima Y, Hafezi-Moghadam A. Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. Exp Eye Res. 2009; 89: 774-81
  144. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro) renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes. 2009; 58: 1625-33
  145. Sasaki M, Ozawa Y, Kurihara T, Noda K, Imamura Y, Kobayashi S, Ishida S, Tsubota K. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci. 2009; 50: 1433-9
  146. Hashizume K, Hirasawa M, Imamura Y, Noda S, Shimizu T, Shinoda K, Kurihara T, Noda K, Ozawa Y, Ishida S, Miyake Y, Shirasawa T, Tsubota K. Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice. Am J Pathol. 2008; 172: 325-31
  147. Hisatomi T, Nakazawa T, Noda K, Almulki L, Miyahara S, Nakao S, Ito Y, She H, Kohno R, Michaud N, Ishibashi T, Hafezi-Moghadam A, Badley AD, Kroemer G, Miller JW. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest. 2008; 118: 2025-38
  148. Noda K, She H, Nakazawa T, Hisatomi T, Nakao S, Almulki L, Zandi S, Miyahara S, Ito Y, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Mashima Y, Hafezi-Moghadam A. Vascular adhesion protein-1 blockade suppresses choroidal neovascularization. FASEB J. 2008; 22: 2928-35
  149. Kurihara T, Ozawa Y, Nagai N, Shinoda K, Noda K, Imamura Y, Tsubota K, Okano H, Oike Y, Ishida S. Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes. 2008; 57: 2191-8
  150. Miyahara S, Almulki L, Noda K, Nakazawa T, Hisatomi T, Nakao S, Thomas KL, Schering A, Zandi S, Frimmel S, Tayyari F, Garland RC, Miller JW, Gragoudas ES, Masli S, Hafezi-Moghadam A. In vivo imaging of endothelial injury in choriocapillaris during endotoxin-induced uveitis. FASEB J. 2008; 22: 1973-80
  151. Noda K, Miyahara S, Nakazawa T, Almulki L, Nakao S, Hisatomi T, She H, Thomas KL, Garland RC, Miller JW, Gragoudas ES, Kawai Y, Mashima Y, Hafezi-Moghadam A. Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis. FASEB J. 2008; 22: 1094-1103
  152. Satofuka S, Ichihara A, Nagai N, Noda K, Ozawa Y, Fukamizu A, Tsubota K, Itoh H, Oike Y, Ishida S. (Pro) renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system. Am J Pathol. 2008; 173: 1911-1918
  153. She H, Nakazawa T, Matsubara A, Connolly E, Hisatomi T, Noda K, Kim IK, Gragoudas ES, Miller JW. Dexamethasone reduces photoreceptor damage caused by photodynamic therapy in a rat model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2008; 49: 5008-5014
  154. Skondra D, Noda K, Almulki L, Tayyari F, Frimmel S, Nakazawa T, Kim IK, Zandi S, Thomas KL, Miller JW, Gragoudas ES, Hafezi-Moghadam A. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown. Invest Ophthalmol Vis Sci. 2008; 49: 726-731
  155. Hafezi-Moghadam A, Noda K, Almulki L, Iliaki EF, Poulaki V, Thomas KL, Nakazawa T, Hisatomi T, Miller JW, Gragoudas ES. VLA-4 blockade suppresses endotoxin-induced uveitis: in vivo evidence for functional integrin up-regulation. FASEB J. 2007; 21: 464-474
  156. Hisatomi T, Sonoda KH, Ishikawa F, Qiao H, Nakamura T, Fukata M, Nakazawa T, Noda K, Miyahara S, Harada M, Kinoshita S, Hafezi-Moghadam A, Ishibashi T, Miller JW. Identification of resident and inflammatory bone marrow derived cells in the sclera by bone marrow and hematopoietic stem cell transplantation. Br J Ophthalmol. 2007; 91: 520-526
  157. Kawamura R, Noda K, Negishi K, Shinoda K, Ishida S, Inoue M, Tsubota K. Intraoperative dehiscence of laser subepithelial keratomileusis (LASEK) flap during retinal detachment surgery. Acta Ophthalmol Scand. 2007; 85: 459
  158. Koto T, Nagai N, Mochimaru H, Kurihara T, Izumi-Nagai K, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Oike Y, Ishida S. Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci. 2007; 48: 4328-4334
  159. Matsubara A, Nakazawa T, Noda K, She H, Connolly E, Young TA, Ogura Y, Gragoudas ES, Miller JW. Photodynamic therapy induces caspase-dependent apoptosis in rat CNV model. Invest Ophthalmol Vis Sci. 2007; 48: 4741-4747
  160. Nagai N, Ishida S, Shinoda K, Imamura Y, Noda K, Inoue M. Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand. 2007; 85: 883-889
  161. Nagai N, Oike Y, Izumi-Nagai K, Koto T, Satofuka S, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Ishida S. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin. Invest Ophthalmol Vis Sci. 2007; 48: 2321-6
  162. Nakao S, Hata Y, Miura M, Noda K, Kimura YN, Kawahara S, Kita T, Hisatomi T, Nakazawa T, Jin Y, Dana MR, Kuwano M, Ono M, Ishibashi T, Hafezi-Moghadam A. Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis. Am J Pathol. 2007; 171: 1058-1065
  163. Nakazawa T, Hisatomi T, Nakazawa C, Noda K, Maruyama K, She H, Matsubara A, Miyahara S, Nakao S, Yin Y, Benowitz L, Hafezi-Moghadam A, Miller JW. From the cover: Monocyte chemoattractant protein 1 mediates retinal detachment-induced photoreceptor apoptosis. Proc Natl Acad Sci U S A. 2007; 104: 2425-2430
  164. Satofuka S, Ichihara A, Nagai N, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Itoh H, Oike Y, Ishida S. Role of nonproteolytically activated prorenin in pathologic, but not physiologic, retinal neovascularization. Invest Ophthalmol Vis Sci. 2007; 48: 422-429
  165. Nagai N, Oike Y, Izumi-Nagai K, Urano T, Kubota Y, Noda K, Ozawa Y, Inoue M, Tsubota K, Suda T, Ishida S. Angiotensin II type 1 receptor-mediated inflammation is required for choroidal neovascularization. Arterioscler Thromb Vasc Biol. 2006; 26: 2252-9
  166. Nakazawa T, Matsubara A, Noda K, Hisatomi T, She H, Skondra D, Miyahara S, Sobrin L, Thomas KL, Chen DF, Grosskreutz CL, Hafezi-Moghadam A, Miller JW. Characterization of cytokine responses to retinal detachment in rats. Mol Vis. 2006; 12: 867-78
  167. Nakazawa T, Nakazawa C, Matsubara A, Noda K, Hisatomi T, She H, Michaud N, Hafezi-Moghadam A, Miller JW, Benowitz LI. Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma. J Neurosci. 2006; 26: 12633-41
  168. Satofuka S, Ichihara A, Nagai N, Yamashiro K, Koto T, Shinoda H, Noda K, Ozawa Y, Inoue M, Tsubota K, Suzuki F, Oike Y, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci. 2006; 47: 2686-92
  169. Kurihara T, Noda K, Ishida S, Inoue M. Pars plana vitrectomy with internal limiting membrane removal for macular hole associated with proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol. 2005; 243: 724-726
  170. Nagai N, Noda K, Urano T, Kubota Y, Shinoda H, Koto T, Shinoda K, Inoue M, Shiomi T, Ikeda E, Tsubota K, Suda T, Oike Y, Ishida S. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 1078-1084
  171. Nagai N, Oike Y, Noda K, Urano T, Kubota Y, Ozawa Y, Shinoda H, Koto T, Shinoda K, Inoue M, Tsubota K, Yamashiro K, Suda T, Ishida S. Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci. 2005; 46: 2925-31
  172. Noda K, Ishida S, Shinoda H, Koto T, Aoki T, Tsubota K, Oguchi Y, Okada Y, Ikeda E. Hypoxia induces the expression of membrane-type 1 matrix metalloproteinase in retinal glial cells. Invest Ophthalmol Vis Sci. 2005; 46: 3817-24
  173. Inoue M, Yamazaki K, Shinoda K, Ishida S, Shinoda H, Noda K, Oguchi Y. A clinicopathologic case report on macular hole associated with von Hippel-Lindau disease: a novel ultrastructural finding of wormlike, wavy tangles of filaments. Graefes Arch Clin Exp Ophthalmol. 2004; 242: 881-886
  174. Inoue M, Noda K, Ishida S, Yamaguchi T, Nagai N, Shinoda K, Shinoda H, Oguchi Y. Successful treatment of subfoveal choroidal neovascularization associated with combined hamartoma of the retina and retinal pigment epithelium. Am J Ophthalmol. 2004; 138: 155-156
  175. Inoue M, Noda K, Ishida S, Nagai N, Imamura Y, Oguchi Y. Intraoperative breakage of a 25-gauge vitreous cutter. Am J Ophthalmol. 2004; 138: 867-9
  176. Inoue M, Shinoda K, Ishida S, Shinoda H, Nagai N, Noda K, Oguchi Y. Treatment of retinal detachment after macular translocation with scleral infolding: preservation of macular translocation. Retina. 2004; 24: 962-4
  177. Noda K, Ishida S, Inoue M, Obata K, Oguchi Y, Okada Y, Ikeda E. Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci. 2003; 44: 2163-70
  178. Mashima Y, Nakamura Y, Noda K, Konishi M, Yamada M, Kudoh J, Shimizu N. A novel mutation at codon 124 (R124L) in the BIGH3 gene is associated with a superficial variant of granular corneal dystrophy. Arch Ophthalmol. 1999; 117: 90-3
  179. Noda K, Mashima Y, Nakamura Y, Tanaka Y. Blepharophimosis-ptosis -epicanthus inversus syndrome associated with interstitial deletion of chromosome 3q21-23. J Pediatr Ophthalmol Strabismus. 1998; 35: 242-3